Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine

Publisher： Karger

E-ISSN： 1421-9824|35|1-2|23-33

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.35, Iss.1-2, 2013-01, pp. : 23-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors Associated with Greater Adherence to and Satisfaction with Transdermal Rivastigmine in Patients with Alzheimer's Disease and Their Caregivers

By  

Dementia and Geriatric Cognitive Disorders, Vol. 40, Iss. 1-2, 2015-06 ,pp. : 107-119

Karger

Access to resources Recommend Favorite

Domain-Specific Improvement of Cognition on Memantine in Patients with Alzheimer’s Disease Treated with Rivastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 5, 2007-03 ,pp. : 301-306

Karger

Access to resources Recommend Favorite

Rivastigmine in the Treatment of Alzheimer’s Disease

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 110-110

Karger

Access to resources Recommend Favorite

Does Rivastigmine Improve Cognitive Functions or Disability in Patients with Alzheimer’s Disease?

By  

Neuroepidemiology, Vol. 23, Iss. 4, 2004-07 ,pp. : 209-210

Karger

Access to resources Recommend Favorite

An Open-Label, Multicenter Observational Study for Patients with Alzheimer’s Disease Treated with Memantine in the Clinical Practice

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-01 ,pp. : 10-19

Karger

Access to resources Recommend Favorite